UTHR United Therapeutics Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
✂ Trimmed✓
◦ Others✓
Time Author Thesis Company / ticker Signal Since call Source
21:13
May 13
TBPN
United Therapeutics pioneers orbital drug manufacturing
United Therapeutics is the first large publicly traded company using its own balance sheet to manufacture physical drug products in low Earth orbit with Varda. Microgravity crystallization can improve formulations and shift administration from IV to subcutaneous or oral to inhalable, expanding access in rare pulmonary disease.
UTHR United Therapeutics Long 1ST —

About UTHR Investor Commentary

Across the available history and selected sources, Buzzberg tracks UTHR (United Therapeutics) across 3 sources: 1 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 17% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 6 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Delian Asparouhov.